The document outlines the intended use, indications, and limitations of several FDA-approved liquid chromatography systems and mass spectrometers for clinical diagnostic laboratories. It emphasizes the equipment's suitability for in vitro diagnostic applications, the importance of certified personnel, and the overall benefits of improved efficiency, selectivity, and productivity in laboratory developed tests. Additionally, it highlights specific instruments, their functionalities, and the need for integration with laboratory information systems.